Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Adv Exp Med Biol ; 923: 215-222, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27526146

RESUMEN

Pyrroloquinoline quinone (PQQ) is a quinone compound originally identified in methanol-utilizing bacteria and is a cofactor for redox enzymes. At the Meeting of the International Society on Oxygen Transport to Tissue (ISOTT) 2014, we reported that PQQ disodium salt (BioPQQ™) improved cognitive function in humans, as assessed by the Stroop test. However, the physiological mechanism of PQQ remains unclear. In the present study, we measured regional cerebral blood flow (rCBF) and oxygen metabolism in prefrontal cortex (PFC), before and after administration of PQQ, using time-resolved near-infrared spectroscopy (tNIRS). A total of 20 healthy subjects between 50 and 70 years of age were administered BioPQQ™ (20 mg) or placebo orally once daily for 12 weeks. Hemoglobin (Hb) concentration and absolute tissue oxygen saturation (SO2) in the bilateral PFC were evaluated under resting conditions using tNIRS. We found that baseline concentrations of hemoglobin and total hemoglobin in the right PFC significantly increased after administration of PQQ (p < 0.05). In addition, decreases in SO2 level in the PFC were more pronounced in the PQQ group than in the placebo group (p < 0.05). These results suggest that PQQ causes increased activity in the right PFC associated with increases in rCBF and oxygen metabolism, resulting in enhanced cognitive function.


Asunto(s)
Antioxidantes/administración & dosificación , Circulación Cerebrovascular/efectos de los fármacos , Suplementos Dietéticos , Consumo de Oxígeno/efectos de los fármacos , Oxígeno/sangre , Cofactor PQQ/administración & dosificación , Corteza Prefrontal/irrigación sanguínea , Corteza Prefrontal/efectos de los fármacos , Administración Oral , Anciano , Biomarcadores/sangre , Velocidad del Flujo Sanguíneo , Método Doble Ciego , Femenino , Voluntarios Sanos , Humanos , Masculino , Persona de Mediana Edad , Oximetría/métodos , Oxihemoglobinas/metabolismo , Corteza Prefrontal/metabolismo , Espectroscopía Infrarroja Corta , Tokio
2.
Biosci Biotechnol Biochem ; 80(1): 13-22, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-26168402

RESUMEN

Pyrroloquinoline quinone (PQQ), an aromatic tricyclic o-quinone, was identified initially as a redox cofactor for bacterial dehydrogenases. Although PQQ is not biosynthesized in mammals, trace amounts of PQQ have been found in human and rat tissues because of its wide distribution in dietary sources. Importantly, nutritional studies in rodents have revealed that PQQ deficiency exhibits diverse systemic responses, including growth impairment, immune dysfunction, and abnormal reproductive performance. Although PQQ is not currently classified as a vitamin, PQQ has been implicated as an important nutrient in mammals. In recent years, PQQ has been receiving much attention owing to its physiological importance and pharmacological effects. In this article, we review the potential health benefits of PQQ with a focus on its growth-promoting activity, anti-diabetic effect, anti-oxidative action, and neuroprotective function. Additionally, we provide an update of its basic pharmacokinetics and safety information in oral ingestion.


Asunto(s)
Antioxidantes/farmacología , Suplementos Dietéticos , Hipoglucemiantes/farmacología , Memoria/efectos de los fármacos , Fármacos Neuroprotectores/farmacología , Cofactor PQQ/farmacología , Animales , Antioxidantes/metabolismo , Antioxidantes/farmacocinética , Regulación de la Expresión Génica , Glucosa/metabolismo , Humanos , Hipoglucemiantes/metabolismo , Hipoglucemiantes/farmacocinética , Insulina/genética , Insulina/metabolismo , Aprendizaje por Laberinto/efectos de los fármacos , Memoria/fisiología , Fármacos Neuroprotectores/metabolismo , Fármacos Neuroprotectores/farmacocinética , Oxidación-Reducción , Cofactor PQQ/metabolismo , Cofactor PQQ/farmacocinética , Proteína Tirosina Fosfatasa no Receptora Tipo 1/genética , Proteína Tirosina Fosfatasa no Receptora Tipo 1/metabolismo , Ratas , Receptor de Insulina/genética , Receptor de Insulina/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA